D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MRVI holding history
Maravai Lifesciences Holdings, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRVI overviewAll 13F holders of MRVIFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −119,123−100.0% | Sold out | Holders |
| Q3 2024 | 119,123 | $989.9K | <0.1% | −364,437−75.4% | Reduced | Holders |
| Q2 2024 | 483,560 | $3.46M | <0.1% | −1,119,676−69.8% | Reduced | Holders |
| Q1 2024 | 1,603,236 | $13.9M | <0.1% | +370,737+30.1% | Added | Holders |
| Q4 2023 | 1,232,499 | $8.07M | <0.1% | +463,246+60.2% | Added | Holders |
| Q3 2023 | 769,253 | $7.69M | <0.1% | +200,971+35.4% | Added | Holders |
| Q2 2023 | 568,282 | $7.06M | <0.1% | −582,061−50.6% | Reduced | Holders |
| Q1 2023 | 1,150,343 | $16.1M | <0.1% | −288,361−20.0% | Reduced | Holders |
| Q4 2022 | 1,438,704 | $20.6M | <0.1% | +621,160+76.0% | Added | Holders |
| Q3 2022 | 817,544 | $20.9M | <0.1% | +330,568+67.9% | Added | Holders |
| Q2 2022 | 486,976 | $13.8M | <0.1% | +106,595+28.0% | Added | Holders |
| Q1 2022 | 380,381 | $13.4M | <0.1% | +431+0.1% | Added | Holders |
| Q4 2021 | 379,950 | $15.9M | <0.1% | −264,852−41.1% | Reduced | Holders |
| Q3 2021 | 644,802 | $31.6M | <0.1% | +308,421+91.7% | Added | Holders |
| Q2 2021 | 336,381 | $14.0M | <0.1% | +336,381 | New | Holders |